EP Patent
EP1037607A1 — Novel suppository form comprising an acid-labile active compound
Assigned to DR. RANGO DIETRICH · Expires 2000-09-27 · 26y expired
What this patent protects
A new administration form for acid-labile active compounds is described. The administraton form is a suppository, in particular for rectal administration.
USPTO Abstract
A new administration form for acid-labile active compounds is described. The administraton form is a suppository, in particular for rectal administration.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.